摘要
Abstract
Objective:To explore the clinical treatment of liver cirrhosis with portal hypertension.Methods:40 patients with liver cirrhosis with portal hypertension were selected.They were randomly divided into the control group and the observation group.The control group were treated with routine treatment,and the observation group was treated with valsartan on the basis of conventional therapy.Before and after treatment,the velocity and diameter of portal veins and splenic veins were examined by color Doppler ultrasound.In the whole course of treatment,patients heart rate,blood pressure,liver and kidney function,blood routine were monitoring.Results:In the observation group,compared with before treatment,portal vein and splenic vein flow velocity,diameter had the obvious change,and the difference had statistical significance(P<0.05);The patient's heart rate,blood pressure did not change obviously,the liver and kidney function and blood routine in patients were without apparent damage;in the control group, the indexes of patients had no obvious change.Conclusion:Valsartan used in liver cirrhosis with portal hypertension patients can effectively improve the blood flow velocity of patients and reduce portal pressure of patients,and it has no effect on the liver and kidney function,toutine blood test,heart rate,blood pressure and so on.It has better clinical therapeutic effect.关键词
肝硬化门静脉高压症/临床治疗/缬沙坦Key words
Liver cirrhosis and portal hypertension/Clinical treatment/Valsartan
